OPTION-EMEA Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT07349121
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT07349121
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium, Croatia, France, Italy, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07349121. Allocation not applicable; no masking; primary purpose other. Start 2026-06-18 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- OPTION-EMEA Clinical Trial
- Acronym
- OPTION-EMEA
- Condition
- Atrial Fibrillation (AF)
- Condition
- Stroke Prevention in Patients With Atrial Fibrillation
- Condition
- Left Atrial Appendage Closure
- Condition
- Pulsed Field Ablation
- Condition
- Atrial Fibrillation Ablation Procedure
- Condition
- Concomitant Procedures
- Intervention (Device)
- Concomitant pulsed field ablation (PFA) and left atrial appendage closure (LAAC) during one interventional case
- Intervention (Procedure)
- Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct07349121- Content hash
cc5c33d6c5fb58744273455d30e0d543c3f6c14a9e31f5c04521c2b8fc523a35